Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dan S. Veljovich"'
Autor:
Dan S Veljovich, Richard T Penson, Michael J Birrer, Gráinne Long, Graham Wetherill, Stephanie Volpe
Publikováno v:
Ovarian cancer.
Autor:
Charles W. Drescher, J Press, Amy E. Bondurant, F Musa, N Kretzer, Dan S. Veljovich, Chirag A. Shah
Publikováno v:
E-Posters.
Autor:
John B. Liao, Chirag A. Shah, Dan S. Veljovich, Pam Paley, Nadia V. Giannakopoulos, Tiffany L. Beck
Publikováno v:
Journal of Gynecologic Oncology
OBJECTIVE The use of robotic radical hysterectomy has greatly increased in the treatment of early stage cervical cancer. We sought to compare surgical and oncologic outcomes of women undergoing robotic radical hysterectomy compared to open radical hy
Autor:
Pamela J. Paley, Kathryn F. McGonigle, Jacqueline Vuky, Benjamin E. Greer, Barbara A. Goff, Howard G. Muntz, Dan S. Veljovich, T. W. Malpass, Heidi J. Gray
Publikováno v:
Cancer. 117:3731-3740
BACKGROUND: A phase 2 trial was conducted to determine the toxicity and efficacy of combined weekly topotecan and biweekly bevacizumab in patients with primary or secondary platinum-resistant ovarian, peritoneal, or fallopian tube cancer (OC). METHOD
Publikováno v:
Gynecologic Oncology. 110:146-151
Objective To determine the nature and degree of toxicity, response rate, quality of life (QOL), and progression-free interval in women with platinum-resistant refractory ovarian or peritoneal cancer receiving weekly topotecan and gemcitabine. Methods
Autor:
Dan S. Veljovich, Christina Isacson, Ellen S. Pizer, Joshua Z. Press, Chirag A. Shah, Pamela J. Paley
Publikováno v:
American journal of obstetrics and gynecology. 215(1)
Background The accuracy of sentinel lymph node mapping has been shown in endometrial cancer, but studies to date have primarily focused on cohorts at low risk for nodal involvement. In our practice, we acknowledge the lack of benefit of lymphadenecto
Autor:
H Sloan, W Peters, Amy E. Bondurant, E Ellis, James Moon, E Johnston, SE Rivkin, M Klee, Gary E. Goodman, Charles W. Drescher, M Fer, M Park, T Wahl, P Jiang, Dan S. Veljovich, K Ference, Henry S. Kaplan, C Wiseman, D Iriarte, Chirag A. Shah
Publikováno v:
Clinical Cancer Research. 23:AP30-AP30
BACKGROUND: We established the olaparib tablet maximum tolerated dose (MTD) at 150 mg bid, dose limiting toxicities (DLT's) and response to therapy or carboplatin, paclitaxel and olaparib tablet given simultaneously, reported at ASCO 2014. This abstr
Autor:
William A. Peters, Charles W. Drescher, Ellen S. Pizer, Chirag A. Shah, Dan S. Veljovich, Pamela J. Paley
Publikováno v:
Gynecologic Oncology. 103:1130-1132
Background. Malignant transformation of endometriosis is an infrequent complication of endometriosis. Extragonadal disease is uncommon. Case. 55-year-old female presented with postmenopausal bleeding. Physical examination revealed a 2-cm polypoid les
Autor:
Dan S. Veljovich
Publikováno v:
Reoperative Pelvic Surgery ISBN: 9780387899985
Despite published recommendations for gynecologic oncology consultation in patients with endometrial cancer or suspicious adnexal masses, patients still undergo surgical evaluation for these conditions in settings where surgical staging is either not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60a0897621b1c74ec0b6b2681628955f
https://doi.org/10.1007/b14187_5
https://doi.org/10.1007/b14187_5
Autor:
Pamela J. Paley, Charles W. Drescher, Elise N. Everett, Dan S. Veljovich, Chirag A. Shah, William A. Peters
Publikováno v:
American journal of obstetrics and gynecology. 198(6)
The objective of the study was to evaluate outcomes during the first year of a robotic surgery program in gynecologic oncology.We studied the initiation of a robotic surgery program with prospective data collection, including intraoperative times, es